Commitments and Contingencies (Details) - Smerud Medical Research International [Member] - USD ($) $ in Thousands		9 Months Ended	12 Months Ended
Nov. 10, 2020	Sep. 30, 2021	Dec. 31, 2020
Commitments and Contingencies (Details) [Line Items]
Development costs			$ 1,191
Development costs		$ 1,191
Royalties on future revenue percentage	7.50%
Future royalties		$ 139

The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 932
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-10(c)(7)(ii))
-URI http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862

Name:	us-gaap_DevelopmentCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration